5.00
前日終値:
$5.14
開ける:
$5.06
24時間の取引高:
181.09K
Relative Volume:
0.79
時価総額:
$153.16M
収益:
$71.61M
当期純損益:
$-48.59M
株価収益率:
-2.8555
EPS:
-1.751
ネットキャッシュフロー:
$-32.88M
1週間 パフォーマンス:
+1.83%
1か月 パフォーマンス:
+26.58%
6か月 パフォーマンス:
+24.69%
1年 パフォーマンス:
-45.71%
Avita Medical Inc Stock (RCEL) Company Profile
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
RCEL
Avita Medical Inc
|
5.00 | 157.45M | 71.61M | -48.59M | -32.88M | -1.751 |
|
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
|
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-05 | 開始されました | Northland Capital | Outperform |
| 2025-11-20 | アップグレード | BTIG Research | Sell → Neutral |
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
Why this ASX healthcare stock is surging while the market sinks on Middle East fears - MSN
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - 富途牛牛
ALERT: Price-sensitive ASX Announcement for AVH - intelligentinvestor.com.au
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association - Investing News Network
The pioneer behind spray-on skin wins burn care’s top honor - Stock Titan
Avita Medical (RCEL) Soars 14.1%: Is Further Upside Left in the Stock? - Yahoo Finance
Avita Medical (RCEL) Achieves Key Milestone in Skin Grafting Stu - GuruFocus
AVITA Medical Reports Accelerating Grafting Times in Positive Interim Results for Cohealyx-I Study - smallcaps.com.au
AVITA Medical up on Cohealyx data on grafting (RCEL:NASDAQ) - Seeking Alpha
Avita Medical Shares Rise on Preliminary Study Results - Moomoo
AVITA Medical Announces Positive Interim Results from Cohealyx® Study - National Today
AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting - Investing News Network
AVITA Medical IncCohealyx Study Full Datas - Moomoo
Skin grafts in 11 days: AVITA posts interim Cohealyx wound data - Stock Titan
AVITA Medical Announces Positive Interim Results from Cohealyx Study Demonstrating Accelerated Time to Skin Grafting - Bitget
AVITA Medical, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
RCEL Technical Analysis & Stock Price Forecast - Intellectia AI
[EFFECT] AVITA Medical, Inc. SEC Filing - Stock Titan
AVH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
AVITA Medical (RCEL) Secures $25.5M BARDA Deal for RECELL Deployment - GuruFocus
AVITA Medical: Why The BARDA Rally Changes Nothing (NASDAQ:RCEL) - Seeking Alpha
AVITA Medical stock gains on BARDA contract (RCEL:NASDAQ) - Seeking Alpha
AVITA Medical secures $25.5M BARDA burn preparedness contract By Investing.com - Investing.com Canada
Avita Medical (RCEL) Secures 10-Year Agreement with BARDA for Bu - GuruFocus
AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness - Investing News Network
AVITA Medical (AVHHL) asks shareholders to OK $900K director fee pool, 650K warrants - Stock Titan
AVITA wins U.S. burn response deal covering 3,000 emergency units - Stock Titan
Chipmakers Recap: How cyclical is AVITA Medical Incs revenue streamQuarterly Risk Review & Fast Entry and Exit Trade Plans - baoquankhu1.vn
RCEL: Analyst Maintains Buy Rating, Target Price at $10.00 | RCE - GuruFocus
Avita Medical (NASDAQ:RCEL) Given Buy Rating at D. Boral Capital - MarketBeat
AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data - Investing News Network
A burn treatment cut hospital stays 36% as AVITA lines up 19 ABA talks - Stock Titan
Aug Fed Impact: Is AVITA Medical Inc stock forming a triangle patternQuarterly Portfolio Report & High Return Trade Guides - baoquankhu1.vn
RCEL PE Ratio & Valuation, Is RCEL Overvalued - Intellectia AI
AVITA Medical, Inc. (NASDAQ:RCEL) Q4 2025 earnings call transcript - MSN
RCEL Should I Buy - Intellectia AI
AVITA Medical Inc (51KB.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):